Impact of serial biopsies in triple-negative breast cancer patients receiving neoadjuvant systemic therapy

被引：0
|
作者：
Yam, C.
Raghavendra, A.
Hess, K. R.
Adrada, B. E.
Candelaria, R. P.
Damodaran, S.
Gilcrease, M. Z.
Helgason, T.
Hortobagyi, G. N.
Huo, L.
Layman, R. M.
Lim, B.
Litton, J. K.
Mittendorf, E. A.
Murthy, R. K.
Piwnica-Worms, H.
Rauch, G. M.
Santiago, L.
Symmans, F.
Thompson, A. M.
Tripathy, D.
Ueno, N. T.
Valero, V.
Barcenas, C. H.
Moulder, S. L.
Yang, W.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P1-15-06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-15-06
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Impact of metaplastic histology (MpBC) in triple-negative breast cancer (TNBC) patients (pts) receiving neoadjuvant systemic therapy (NAST)
    Yam, Clinton
    Hess, Kenneth R.
    Litton, Jennifer Keating
    Yang, Wei Tse
    Santiago, Lumarie
    Candelaria, Rosalind P.
    Mittendorf, Elizabeth A.
    Murthy, Rashmi Krishna
    Damodaran, Senthil
    Helgason, Thorunn
    Huo, Lei
    Thompson, Alastair Mark
    Barton, Michelle
    Huang, Monica L.
    Arribas, Elsa M.
    Lane, Deanna L.
    Rauch, Gaiane M.
    Adrada, Beatriz E.
    Gilcrease, Michael Z.
    Moulder, Stacy L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Surgical Outcomes in Patients Receiving Pembrolizumab Containing Neoadjuvant Systemic Therapy Regimens for Triple-negative Breast Cancer
    Woodfin, Ashley
    Yam, Clinton
    Teshome, Mediget
    Kuerer, Henry
    Hunt, Kelly K.
    Meric-Bernstam, Funda
    Barcenas, Carlos
    Sun, Susie
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 2) : S492 - S493
  • [3] Efficacy of neoadjuvant systemic carboplatin therapy in triple-negative breast cancer
    Thomssen, Christoph
    Schuler, Kathleen
    Bauer, Marcus
    Reinhardt, Kristin
    Strauss, Hans-Gerorg
    Vetter, Martina
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [4] Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients
    Candelaria, Rosalind P.
    Adrada, Beatriz E.
    Hess, Kenneth
    Santiago, Lumarie
    Lane, Deanna L.
    Thompson, Alastair M.
    Moulder, Stacy L.
    Huang, Monica L.
    Arribas, Elsa M.
    Rauch, Gaiane M.
    Leung, Jessica W. T.
    Symmans, W. Fraser
    Valero, Vicente
    Ravenberg, Elizabeth E.
    White, Jason B.
    Yang, Wei Tse
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2020, 130
  • [5] The prognosis of effectiveness neoadjuvant therapy in patients with triple-negative breast cancer
    Vyzhigina, B.
    [J]. BREAST, 2019, 44 : S67 - S67
  • [6] Progress in systemic therapy for triple-negative breast cancer
    Hongnan Mo
    Binghe Xu
    [J]. Frontiers of Medicine., 2021, 15 (01) - 10
  • [7] Progress in systemic therapy for triple-negative breast cancer
    Mo, Hongnan
    Xu, Binghe
    [J]. FRONTIERS OF MEDICINE, 2021, 15 (01) : 1 - 10
  • [8] Progress in systemic therapy for triple-negative breast cancer
    Hongnan Mo
    Binghe Xu
    [J]. Frontiers of Medicine, 2021, 15 : 1 - 10
  • [9] Future Developments in Neoadjuvant Therapy for Triple-Negative Breast Cancer
    Moore-Smith, Lakisha
    Forero-Torres, Andres
    Stringer-Reasor, Erica
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 2018, 98 (04) : 773 - +
  • [10] Locoregional recurrence in patients with early-stage triple-negative breast cancer receiving neoadjuvant systemic therapy: Patient characteristics and clinical outcomes
    Haiderali, Amin
    Rhodes, Whitney C.
    Gautam, Santosh
    Huang, Min
    Sieluk, Jan
    Skinner, Karen E.
    Schwartzberg, Lee S.
    [J]. CANCER RESEARCH, 2021, 81 (04)
12345